The neuropsychiatry of chronic cocaine abuse.

Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci (2004) 1.96

Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci U S A (2003) 1.71

Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev (2008) 1.52

Review. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philos Trans R Soc Lond B Biol Sci (2008) 1.37

Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology (2008) 1.36

Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend (2002) 1.35

Impaired inhibitory control in recreational cocaine users. PLoS One (2007) 1.24

Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr (2011) 1.16

Functional MRI and response inhibition in children exposed to cocaine in utero. Preliminary findings. Dev Neurosci (2009) 1.14

Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). Psychopharmacology (Berl) (2006) 1.12

Methylphenidate Abuse and Psychiatric Side Effects. Prim Care Companion J Clin Psychiatry (2000) 1.11

Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology (2010) 1.10

Influence of cocaine self-administration on learning related to prefrontal cortex or hippocampus functioning in rats. Psychopharmacology (Berl) (2005) 1.05

Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Drug Alcohol Depend (2010) 0.98

Reduced spontaneous eye blink rates in recreational cocaine users: evidence for dopaminergic hypoactivity. PLoS One (2008) 0.97

Brain damages in ketamine addicts as revealed by magnetic resonance imaging. Front Neuroanat (2013) 0.97

Recreational cocaine polydrug use impairs cognitive flexibility but not working memory. Psychopharmacology (Berl) (2009) 0.97

Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc (2005) 0.95

Reward, interrupted: Inhibitory control and its relevance to addictions. Neuropharmacology (2013) 0.94

The effects of abused drugs on adolescent development of corticolimbic circuitry and behavior. Neuroscience (2013) 0.94

Intrauterine cocaine exposure and executive functioning in middle childhood. Neurotoxicol Teratol (2008) 0.94

Cocaine and Pavlovian fear conditioning: dose-effect analysis. Behav Brain Res (2006) 0.93

Evidence of temporal cortical dysfunction in rhesus monkeys following chronic cocaine self-administration. Cereb Cortex (2007) 0.91

A touch screen based Stop Signal Response Task in rhesus monkeys for studying impulsivity associated with chronic cocaine self-administration. J Neurosci Methods (2008) 0.89

Cocaine and Psychiatric Symptoms. Prim Care Companion J Clin Psychiatry (1999) 0.86

Effects of perceived cocaine availability on subjective and objective responses to the drug. Subst Abuse Treat Prev Policy (2007) 0.85

Prior chronic cocaine exposure in mice induces persistent alterations in cognitive function. Behav Pharmacol (2009) 0.84

Preliminary evidence for normalization of risk taking by modafinil in chronic cocaine users. Addict Behav (2014) 0.83

The primacy of cognition in the manifestations of substance use disorders. Front Neurol (2013) 0.82

The stereotypy-inducing and OCD-like effects of chronic 'binge' cocaine are modulated by distinct subtypes of nicotinic acetylcholine receptors. Br J Pharmacol (2012) 0.82

Latent vulnerability in cognitive performance following chronic cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl) (2012) 0.80

Error processing in current and former cocaine users. Brain Imaging Behav (2014) 0.80

Reduced attentional scope in cocaine polydrug users. PLoS One (2009) 0.80

An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research. Curr Drug Abuse Rev (2015) 0.79

Decreased spontaneous eye blink rates in chronic cannabis users: evidence for striatal cannabinoid-dopamine interactions. PLoS One (2011) 0.78

Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches. Front Psychiatry (2016) 0.78

Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling. J Neurochem (2012) 0.78

Factors related to correctional facility incarceration among active injection drug users in Baltimore, MD. Drug Alcohol Depend (2007) 0.75

Risky Decisions in a Lottery Task Are Associated with an Increase of Cocaine Use. Front Psychol (2016) 0.75

Increased response conflict in recreational cocaine polydrug users. Exp Brain Res (2013) 0.75

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70

Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31

Dose-related neurocognitive effects of marijuana use. Neurology (2002) 3.25

Gender-linked brain injury in experimental stroke. Stroke (1998) 3.08

Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science (1988) 3.01

Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia (2000) 2.82

Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75

Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience (2009) 2.38

Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport (2001) 2.19

Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend (1993) 1.84

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci (1992) 1.79

Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci (1999) 1.77

Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res (2001) 1.71

5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67

Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology (2001) 1.61

Sex-related differences in a gambling task and its neurological correlates. Cereb Cortex (2004) 1.58

17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke (1999) 1.58

Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49

Relative rates of AIDS among racial/ethnic groups by exposure categories. J Natl Med Assoc (1999) 1.49

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res (1990) 1.48

Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain. Anesthesiology (1989) 1.47

Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology (1998) 1.46

Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A (2001) 1.41

Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology (2000) 1.34

Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol (1999) 1.32

Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry (2008) 1.25

Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21

Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem (2001) 1.20

Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology (2000) 1.20

Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci (1999) 1.18

Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J (2001) 1.17

Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann N Y Acad Sci (2001) 1.16

Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain (1983) 1.08

Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol Pharmacol (2000) 1.08

Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke (2001) 1.08

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry (2005) 1.08

Neurovascular deficits in cocaine abusers. Neuropsychopharmacology (1999) 1.06

Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol Psychiatry (2007) 1.05

Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice. Neuroscience (2012) 1.04

2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem (1998) 1.04

Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience (1991) 1.04

Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res (1990) 1.03

Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry (2008) 1.01

Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke (1998) 0.98

Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res (2000) 0.98

Differential effects of age on motor performance in two mouse strains. Neurobiol Aging (1981) 0.98

2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol (1998) 0.98

Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Brain Res Rev (2000) 0.98

Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci (1997) 0.97

Transcriptional responses to reinforcing effects of cocaine in the rat hippocampus and cortex. Genes Brain Behav (2007) 0.97

MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels. Synapse (1994) 0.96

Dual mechanism of Fas-induced cell death in neuroglioma cells: a role for reactive oxygen species. Brain Res Mol Brain Res (1999) 0.95

[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther (1997) 0.95

Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology (Berl) (1996) 0.95

Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. J Pharmacol Exp Ther (1997) 0.95

Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res (1996) 0.95

Methamphetamine-induced increase in striatal NF-kappaB DNA-binding activity is attenuated in superoxide dismutase transgenic mice. Brain Res Mol Brain Res (1998) 0.94

Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Neuroscience (1998) 0.94

Radial maze performance in young and aged mice: neurochemical correlates. Pharmacol Biochem Behav (1985) 0.94

Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology (1995) 0.94

Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain. Eur J Pharmacol (1993) 0.94

Autoradiographic localization of [3H]nicotine binding sites in the rat brain. Neurosci Lett (1985) 0.94

PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke (1996) 0.93

sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke (2000) 0.93

Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull (1988) 0.93

Quantitative neuroanatomy in schizophrenia. A controlled magnetic resonance imaging study. Arch Gen Psychiatry (1988) 0.93

Effects of L-cocaine on local cerebral glucose utilization in the rat. Neurosci Lett (1986) 0.92

Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann N Y Acad Sci (1998) 0.92

Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res (1999) 0.92

Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur J Pharmacol (1998) 0.91

An assessment of the validity of densitometric measures of striatal tyrosine hydroxylase-positive fibers: relationship to apomorphine-induced rotations in 6-hydroxydopamine lesioned rats. J Neurosci Methods (1990) 0.91

6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci (2000) 0.91

Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res Bull (1991) 0.91

Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J Neurosci (1996) 0.91

Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice. J Neurochem (1992) 0.91

Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur J Pharmacol (1999) 0.91

Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab (2009) 0.90

In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci (1998) 0.90

Aging and caloric restriction in nonhuman primates: behavioral and in vivo brain imaging studies. Ann N Y Acad Sci (2001) 0.90

Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Res (1987) 0.90

Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in aged rats. Brain Res (1992) 0.89

PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke (1995) 0.89

Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur J Pharmacol (1997) 0.89

Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging. Neurobiol Aging (2000) 0.89

Sigma receptors in post-mortem human brains. J Pharmacol Exp Ther (1988) 0.89

In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand. Neuroreport (1998) 0.89

High affinity binding of [3H]epibatidine to rat brain membranes. Neuroreport (1999) 0.88

Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology (Berl) (2000) 0.88

No effect of hyperketonemia on local cerebral glucose utilization in conscious rats. J Neurochem (1982) 0.88

Nitric oxide production by lymphatic endothelial cells in vitro. Biochem Biophys Res Commun (1995) 0.88

Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease. Biol Psychiatry (1981) 0.88

Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry (1991) 0.88

Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species. J Pharmacol Exp Ther (1998) 0.88

Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis. Life Sci (1994) 0.88

Marijuana abusers are at increased risk for stroke. Preliminary evidence from cerebrovascular perfusion data. Ann N Y Acad Sci (2001) 0.88

Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation. Neuroscience (2001) 0.87

Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res (1995) 0.87